U.S., Oct. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07863258) titled 'STRATHEP: AI-Driven Treatment Stratification for Advanced Hepatocellular Carcinoma' on Oct. 01.
Brief Summary: STRATHEP develops and validates a multimodal AI model to predict treatment response in advanced hepatocellular carcinoma. By integrating digital pathology and MRI radiomics, the project identifies patients likely to benefit from modern systemic therapies, using the RECIST 1.1 framework as the primary benchmark.
Study Start Date: Oct. 15
Study Type: OBSERVATIONAL
Condition:
Hepatocellular Carcinoma (HCC)
Recruitment Status: RECRUITING
Sponsor: Universitaire Ziekenhuizen KU Leuven
Disclaimer: Curated by HT Syndication....